New Drug Delivery Strategies for Treating Fungal Infection Volume 2 - Issue 3

Narinder Singh*

• Department of pharmaceutics, CT institute of Pharmaceutical Sciences, India

Received: January 20, 2020;   Published: January 30, 2020

*Corresponding author: Narinder Singh, Department of pharmaceutics, CT institute of Pharmaceutical Sciences, Shahpur, Jalandhar, Punjab, India

DOI: 10.32474/ANOAJ.2020.02.000137

Abstract PDF

Systemic Fungal infection of skin is also known as mycosis. Mycosis is a common fungal infection affecting human skin and causes different dermatophyte infections. Fungal infections is panic rate which presenting number of challenge to healthcare professionals. This rising rate is directly related to the growing population of immune compromised individuals thus results from changes in medical practice like use of immunosuppressive drugs and rigorous chemotherapy. Now there are modern aggressive treatment was used to control fungal infection in the body. The purpose of this review is to highlight the different novel diagnostic approaches for treatments for fungal infections.

Keywords: Fungal infection; types; characteristics; conventional; novel drug formulation

Fungal infection (fungus) is that kind of infection which is a germ or microbe that causes infections to mammals. Another words fungus referred as mycology and in plural it is called as fungi. Fungus has become rise throughout the past decade. The fraction of weak patients is rising, paralleling the surplus use of immunological disorder therapies. The circumstances incline the patients to fungal infection have hematopoietic stem cell, transplantation and therapy as well as preterm birth etc. Among the varied opportunist pathogens, fungi express a significant and necessary threat. Fungal microbes are overabundant in nature (Table 1). They are frequent colonizers on varied human tissue layer surfaces, wherever they will live by evading host defenses (Table2).

Table 1: Types of Fungal Infection.

Table 2: Conventional and Novel Delivery Systems for treating fungal infections.

Characteristics of fungi [1]

a. Parasite
b. Identify by reproduction
c. Branched Filaments

Major Antifungal Agents

a. Fluoropyrimidines
b. Polyenes
c. Azoles
d. Echinocandins
e. Polyenes

The best way to deal with the ideal management of fungal infection is firstly finding and identify the causative agents and suitable treatment could be began as soon as possible (Table 3). But these days novel treatments are used for the superficial fungal infection. Which reduced the toxicity and increase the efficacy of these drugs. They are more capable of release the drug in sustained or controlled or minimizing the adverse effect of drugs such as allergic reaction and itching [1-28]. Thus, novel drug delivery system would be considered as highly efficient and better alternative for infection.

Table 3: Novel drug formulation used of Fungal Infection.

1. Strober BE, Washenik K, Shupak JL (2003) Principles of topical therapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, (eds.). Fitzpatrick’s dermatology in general medicine, New York, NY: McGrawHill, USA 2: 2319-2323.
2. Jobin J, Narayana Charyulu R (2015) Solubility Enhancement of an Antifungal Agent by Association with Dendrimers. IJRPB 3(2): 171-175.
3. Chouhanand P, Saini TR (2014) Hydroxypropyl-𝛽-Cyclodextrin: A Novel Transungual Permeation Enhancer for Development of Topical Drug Delivery System for Onychomycosis. Journal of Drug Delivery, PP: 1-7.
4. Sevgi G, Sedef EM, Buket A (2013) New Formulation Strategies in Topical Antifungal Therapy. Journal of Cosmetics, Dermatological Sciences and Applications (3): 56-65.
5. Ma Y, Chen X, Guan S (2015) Terbinafine: Novel Formulations that Potentiate Antifungal Activities. Drugs of today 51(3): 197-208.
6. Crowley PD, Gallagher HC (2014) Clotrimazole as a Pharmaceutical: past, present and future. J Appl Microbiol 117(3): 611-617.
7. Tyagi LK, Kumar S, Maurya SS, Kori ML (2013) Ethosomes novel vesicular carrier for enhanced transdermal drug delivery system. Bulletin Pharm Res 3(1): 6-13.
8. Zhang L, Pornpattananangkul D, Huang CM (2010) Development of Nanoparticles for Antimicrobial Drug Delivery. Current Medicinal Chemistry 17(6): 585-594.
9. Asmit K, Rahul A, Mangesh B, Formulation and Evaluation of Itraconazole Emulgel for Topical Drug Delivery.
10. Kshirsagar NA, Pandya SK, Kirodian GB, Sanath S (2005) Liposomal Drug Delivery System from Laboratory to Clinic. J Postgrad Med 51(5): 5-15.
11. Meena D, Murugesan SK, Nanjaian M (2011) Amphotericin-B Loaded Vesicular Systems for the Treatment of Topical Fungal Infection. International Journal of Recent Advances in Pharmaceutical Research 4: 37-46.
12. Manisha K, Vilasrao K, Nikhil M, Vruti P, Namrata J (2013) Formulation and Evaluation of Topical Delivery of Antifungal Drug Bifonazole Using Microemulsion Based Gel Formulation. World Journal of Pharmacy and Pharmaceutical Sciences 2(6): 6405-6422.
13. Mantry S, Patnaik A, Sriram N, Bharath R (2013) Formulation and Evaluation of Bifonazole Organogel as a Novel Topical Drug Delivery System. International Journal of Pharmacy 3(1): 1-8.
14. Rajalakshmi G, Damodharan N, Chaudhary VKVB, Pogal JR (2010) Formulation and Evaluation of Clotrimazole and Ichthammol Ointment. Int J Pharm Bio Sci 1(4): 6-16.
15. Rathore GS, Tanwar YS, Sharma, (2015) Fluconazole Loaded Ethosomes Gel and Liposomes Gel: An Updated Review for the Treatment of Deep Fungal Skin Infection. The Pharmaceutical and Chemical Journal. 2(1):41-50.
16. Basha BN, Kalyani P, Divakar G (2011) Formulation and Evaluation of Gel Containing Fluconazole-Antifungal Agent. International Journal of Drug Development & Research 3(4): 109-128.
17. Kamble A, Adnaik R, Bhutkar M (2014) Formulation and Evaluation of Itraconazole Emulgel for Topical Drug Delivery. International Journal of Universal Pharmacy and Bio Sciences 3(5): 37-45.
18. Deveda P, Jain A, Vyas N, Khambete H, Jain S (2010) Gellified Emulsion for Sustain Delivery of Itraconazole for Topical Fungal Diseases. International Journal of Pharmacy and Pharmaceutical Sciences 2(1): 104-112.
19. Shinde PB (2013) Component Screening of Miconazole Nitrate nanoemulsion. Asian Journal of Biomedical and Pharmaceutical Sciences. 3(19): 33-40.
20. Vij NN, Saudagar RB (2014) Formulation, Development and Evaluation of Film-Forming Gel for Prolonged Dermal Delivery of Terbinafine Hydrochloride. International Journal of Pharma Sciences and Research (IJPSR) 5(9): 537-554.
21. Tumbalam KK (2015) Formulation and Characterization of “Novel Anti-Fungal Drug Candidate” In Gel Dosage Form. Ijppr, Human Journals Research Article 3(4): 203-212.
22. Khairnar GA, Chavan Patil AB, Palve PR, Bhise SB, Mourya VK, et al. (2010) Dendrimers: Potential Tool for Enhancement of Antifungal Activity. International Journal of Pharmtech Research 2(1): 736-739.
23. Bhalaria MK, Naik S, Misra AN (2009) Ethosomes: A Novel Delivery System for Antifungal Drugs in Treatment of Topical Fungal Diseases. Indian Journal of Experimental Biology 47(5): 368-375.
24. Deveda P, Jain A, Vyas N, Khambete H, Jain S (2010) Gellified Emulsion for Sustain Delivery of Itraconazole for Topical Fungal Diseases. International Journal of Pharmacy and Pharmaceutical Sciences 2(1): 104-112.
25. Bhowmik D, Gopinath H, Kumar B P, Duraivel S, Aravind G, et al. (2013) Nail Drug Delivery System-A Novel Approaches for Drug Delivery System. The pharma innovation 1: 3-16.
26. Poornima G, Rani KS, Brahmaiah B, Padmaja K, Pratyusha Ch (2013) Nail Drug Delivery System-A Novel Approaches for Drug Delivery System. International Journal of Advanced Pharmaceutics 3(2): 102-109.
27. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, et al. (2013). "The Global Burden of Skin Disease in 2010: an analysis of the Prevalence and Impact of Skin Conditions." The Journal of Investigative Dermatology134 (6): 1527-1534.
28. Agrawal U, Mehra NK, Gupta U, Jain NK (2013) Hyper branched Dendritic Nano-Carriers for Topical Delivery of Dithranol. Journal of Drug Target 21(5): 497-506.